a Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences , American University of Sharjah , Sharjah , United Arab Emirates.
b Department of Biomedical Science, College of Health Sciences , Qatar University , Doha , Qatar.
Crit Rev Food Sci Nutr. 2017 Dec 12;57(18):3911-3928. doi: 10.1080/10408398.2016.1277971.
Over the past two decades, studies have documented the wide-range anti-cancer effects of Nigella sativa, known as black seed or black cumin. Thymoquinone (TQ), its major active ingredient, has also been extensively studied and reported to possess potent anti-cancer properties. Herein, we provide a comprehensive review of the findings related to the anti-cancer activity of TQ. The review focuses on analyzing experimental studies performed using different in vitro and in vivo models to identify the anti-proliferative, pro-apoptotic, anti-oxidant, cytotoxic, anti-metastatic, and NK-dependent cytotoxic effects exerted by TQ. In addition, we pinpoint the molecular mechanisms underlying these effects and the signal transduction pathways implicated by TQ. Our analysis show that p53, NF-κB, PPARγ, STAT3, MAPK, and PI3K/AKT signaling pathways are among the most significant pathways through which TQ mediates its anti-cancer activity. Experimental findings and recent advances in the field highlight TQ as an effective therapeutic agent for the suppression of tumor development, growth and metastasis for a wide range of tumors.
在过去的二十年中,研究已经记录了黑种草,也被称为黑种草籽或黑孜然,具有广泛的抗癌作用。其主要活性成分,百里醌(TQ)也已被广泛研究,并被报道具有很强的抗癌特性。在此,我们提供了一份关于 TQ 抗癌活性的研究结果的综合综述。该综述重点分析了使用不同的体外和体内模型进行的实验研究,以确定 TQ 发挥的抗增殖、促凋亡、抗氧化、细胞毒性、抗转移和 NK 依赖性细胞毒性作用。此外,我们还确定了这些作用背后的分子机制以及 TQ 涉及的信号转导途径。我们的分析表明,p53、NF-κB、PPARγ、STAT3、MAPK 和 PI3K/AKT 信号通路是 TQ 介导其抗癌活性的最重要途径之一。实验结果和该领域的最新进展强调了 TQ 作为一种有效的治疗剂,可抑制多种肿瘤的肿瘤发展、生长和转移。
Crit Rev Food Sci Nutr. 2017-12-12
Int Immunopharmacol. 2015-6-26
Phytochemistry. 2022-8
Pharmacol Res. 2015
Recent Pat Drug Deliv Formul. 2018
Naunyn Schmiedebergs Arch Pharmacol. 2025-2-11
Clin Transl Oncol. 2024-9
Curr Med Chem. 2025